Qian, Guan, Hu, Han, et al. use mendelian randomization to investigate the cardiovascular effects of genetically proxied sclerostin inhibition, based on multi-omics data. They demonstrate that genetically informed inhibition of sclerostin increases bone density, but attention should be paid to the potential risk of atrial fibrillation.
- Yu Qian
- Peng-Lin Guan
- Hou-Feng Zheng